Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression

A multifactorial syndrome, Alzheimer’s disease is the main cause of dementia, but there is no existing therapy to prevent it or stop its progression. One of the earliest events of Alzheimer’s disease is the disruption of calcium homeostasis but that is just a prelude to the disease’s devastating imp...

Full description

Bibliographic Details
Main Author: Danton H. O’Day
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/45/8/393
_version_ 1797585121154433024
author Danton H. O’Day
author_facet Danton H. O’Day
author_sort Danton H. O’Day
collection DOAJ
description A multifactorial syndrome, Alzheimer’s disease is the main cause of dementia, but there is no existing therapy to prevent it or stop its progression. One of the earliest events of Alzheimer’s disease is the disruption of calcium homeostasis but that is just a prelude to the disease’s devastating impact. Calcium does not work alone but must interact with downstream cellular components of which the small regulatory protein calmodulin is central, if not primary. This review supports the idea that, due to calcium dyshomeostasis, calmodulin is a dominant regulatory protein that functions in all stages of Alzheimer’s disease, and these regulatory events are impacted by amyloid beta. Amyloid beta not only binds to and regulates calmodulin but also multiple calmodulin-binding proteins involved in Alzheimer’s. Together, they act on the regulation of calcium dyshomeostasis, neuroinflammation, amyloidogenesis, memory formation, neuronal plasticity and more. The complex interactions between calmodulin, its binding proteins and amyloid beta may explain why many therapies have failed or are doomed to failure unless they are considered.
first_indexed 2024-03-11T00:02:28Z
format Article
id doaj.art-86f79ce1eb6a415883446077d5e88add
institution Directory Open Access Journal
issn 1467-3037
1467-3045
language English
last_indexed 2024-03-11T00:02:28Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj.art-86f79ce1eb6a415883446077d5e88add2023-11-19T00:41:33ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452023-07-014586246626110.3390/cimb45080393Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through ProgressionDanton H. O’Day0Department of Biology, University of Toronto Mississauga, Mississauga, ON L5L 1C6, CanadaA multifactorial syndrome, Alzheimer’s disease is the main cause of dementia, but there is no existing therapy to prevent it or stop its progression. One of the earliest events of Alzheimer’s disease is the disruption of calcium homeostasis but that is just a prelude to the disease’s devastating impact. Calcium does not work alone but must interact with downstream cellular components of which the small regulatory protein calmodulin is central, if not primary. This review supports the idea that, due to calcium dyshomeostasis, calmodulin is a dominant regulatory protein that functions in all stages of Alzheimer’s disease, and these regulatory events are impacted by amyloid beta. Amyloid beta not only binds to and regulates calmodulin but also multiple calmodulin-binding proteins involved in Alzheimer’s. Together, they act on the regulation of calcium dyshomeostasis, neuroinflammation, amyloidogenesis, memory formation, neuronal plasticity and more. The complex interactions between calmodulin, its binding proteins and amyloid beta may explain why many therapies have failed or are doomed to failure unless they are considered.https://www.mdpi.com/1467-3045/45/8/393Alzheimer’s diseasecalcium dysregulationcalmodulincalmodulin-binding proteinsamyloid betaion channels
spellingShingle Danton H. O’Day
Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression
Current Issues in Molecular Biology
Alzheimer’s disease
calcium dysregulation
calmodulin
calmodulin-binding proteins
amyloid beta
ion channels
title Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression
title_full Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression
title_fullStr Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression
title_full_unstemmed Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression
title_short Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression
title_sort alzheimer s disease beyond calcium dysregulation the complex interplay between calmodulin calmodulin binding proteins and amyloid beta from disease onset through progression
topic Alzheimer’s disease
calcium dysregulation
calmodulin
calmodulin-binding proteins
amyloid beta
ion channels
url https://www.mdpi.com/1467-3045/45/8/393
work_keys_str_mv AT dantonhoday alzheimersdiseasebeyondcalciumdysregulationthecomplexinterplaybetweencalmodulincalmodulinbindingproteinsandamyloidbetafromdiseaseonsetthroughprogression